Revenue: The sum of all revenue fields included for a company's operating activities.
Revolution Medicines, Inc. (RVMD) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-213.42M |
|
-- |
|
-- |
|
$240.76M |
|
$-240.76M |
|
$27.34M |
|
$-213.42M |
|
$-213.42M |
|
$-213.42M |
|
$-213.42M |
|
$-213.42M |
|
$-213.42M |
|
$-240.76M |
|
$-246.86M |
|
188.15M |
|
188.15M |
|
$-1.13 |
|
$-1.13 |
|
| Balance Sheet Financials | |
$2.13B |
|
$27.15M |
|
$230.77M |
|
$2.37B |
|
$158.60M |
|
-- |
|
$128.60M |
|
$287.20M |
|
$2.08B |
|
$2.01B |
|
$2.08B |
|
186.26M |
|
| Cash Flow Statement Financials | |
$-194.44M |
|
$-15.95M |
|
$0.87M |
|
$546.76M |
|
$337.25M |
|
$-209.51M |
|
$25.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-197.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.27% |
|
-10.63% |
|
-9.02% |
|
-10.27% |
|
$11.16 |
|
$-1.05 |
|
$-1.03 |
|